Author:
Gevorgyan M. M.,Voronina N. P.,Goncharova N. V.,Kozaruk T. V.,Russkikh G. S.,Bogdanova L. A.,Korolenko T. A.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference15 articles.
1. Cherkanova MS, Korolenko TA, Yu Brawe I, Gerasimova TP. Effect of statins on activity of matrix metalloproteases and serum concentration of cystatin C in patients with various risk of development of ischemic heart disease and in patients after coronary artery bypass surgery. Kardiologiya. 2012;52(2):23-28. Russian.
2. Bengtsson E, Nilsson J, Jovinge S. Cystatin C and cathepsins in cardiovascular disease. Front Biosci. 2008;13:5780-5786.
3. Frendéus KH, Wallin H, Janciauskiene S, Abrahamson M. Macrophage responses to interferon-gamma are dependent on cystatin C levels. Int. J. Biochem. Cell Biol. 2009;41(11):2262-2269.
4. Grubb A, Blirup-Jensen S, Lindström V, Schmidt C, Althaus H, Zegers I; IFCC Working Group on Standardisation of Cystatin C (WG-SCC). First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin. Chem. Lab. Med. 2010;48(11):1619-1621.
5. Korolenko TA, Cherkanova MS, Gashenko EA, Johnston TP, Bravve IY. Cystatin C, atherosclerosis and lipid-lowering therapy by statins. Cystatins: Protease Inhibitors, Biomarkers and Immunomodulators. Cohen JB, Rysek LP, eds. New York, 2011. P. 187-204.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献